fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Divi's Laboratories Ltd

Divi s Laboratories Ltd

Updated on October 16, 2020

Stock/Share Code - DIVISLAB

Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business...show more

Below is the details of DIVISLAB Divi s Laboratories Ltd

Market Cap₹82,582 Cr.
Current Price ₹3,078.95 as on 21 Oct 20
52 Week High / Low Price₹3,378.65 / ₹1,570.5
Face Value₹2
Stock P/E51.69
Book Value₹275.61
Dividend Yield0.51 %
ROCE24.45 %
ROE18.63 %
Sales Growth (3yrs)9.69 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has been maintaining a healthy dividend payout of 31.11%
Cons: Stock is trading at 11.28 times its book value The company has delivered a poor growth of 11.48% over past five years.

Divi s Laboratories Ltd Price Chart

Divi s Laboratories Ltd Price Chart

Divi s Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹141 51.89 ₹82,900.53 Cr. 0.51 ₹492.25 Cr. 84.12 50.01 1709.96 24.45
2. Lupin ₹1,002.55 ₹42,032.3 Cr. 0.65 ₹106.9 Cr. -64.73 -9.02 3527.86 9.23
3. Jubilant Life ₹706.05 13.50 ₹12,477.17 Cr. 0.64 ₹260.49 Cr. 248.25 0.24 2391.41 15.46
4. Granules India ₹386.35 22.60 ₹7,765.53 Cr. 0.32 ₹111.45 Cr. 33.89 23.57 735.60 17.15
5. Aarti Drugs ₹769.1 31.46 ₹6,319.31 Cr. 0.07 ₹85.45 Cr. 280.62 34.34 544.67 20.87
6. Shilpa Medicare ₹469.25 23.66 ₹4,289.13 Cr. 0.21 ₹86.31 Cr. 159.66 38.43 222.86 12.62
7. Sequent Scien. ₹154.25 40.58 ₹3,221.37 Cr. 0.15 ₹20.92 Cr. 82.55 11.60 310.27 12.29
8. Hikal ₹168.8 23.23 ₹2,004.25 Cr. 0.74 ₹15 Cr. -40.55 -12.50 352.77 13.51

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Divi s Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -8901,0381,0889951,2851,3431,2561,1401,4041,3901,3761,710
YOY Sales Growth %-11%6%2%21%44%29%15%15%9%4%10%50%
Expenses -6137127016437718208457619198949281,011
Material Cost %40.14%39.35%37.47%38.32%36.83%35.76%40.03%39.80%41.13%39.38%37.05%37.23%
Employee Cost %11.77%11.08%11.56%12.19%10.48%10.16%11.01%12.10%10.51%11.01%12.33%10.55%
Operating Profit277326386352514523411379485497449699
OPM %31%31%36%35%40%39%33%33%35%36%33%41%
Other Income341748498035423247407718
Interest10-0103004200
Depreciation343739424242424446475056
Profit before tax276306396358552513410366483489475661
Tax %25%26%34%26%28%26%29%27%27%26%18%26%
Net Profit207225262266398379289267353361392492
EPS in Rs7.798.469.8510.0314.9814.2910.9010.0713.2913.5914.7618.54
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1,1919291,3151,8452,1292,5143,0843,7204,0243,8164,8805,3115,881
Sales Growth %15.28%-21.98%41.49%40.31%15.39%18.09%22.67%20.63%8.17%-5.17%27.88%8.83%
Expenses -7015178091,1491,3061,4921,9142,3142,5832,5613,0303,4943,751
Material Cost %37.29%31.85%40.35%41.92%37.47%36.52%39.41%40.17%39.12%39.44%38.45%40.11%
Manufacturing Cost %6.81%7.99%7.20%6.99%9.49%9.18%8.93%8.47%7.64%10.15%7.95%8.76%
Employee Cost %7.51%10.04%8.53%7.87%8.98%8.97%9.19%9.49%12.19%11.71%10.89%11.48%
Other Cost %7.23%5.80%5.48%5.51%5.42%4.67%4.53%4.08%5.25%5.81%4.80%5.45%
Operating Profit4904125056968231,0221,1701,4061,4401,2551,8501,8162,130
OPM %41%44%38%38%39%41%38%38%36%33%38%34%36%
Other Income233129664981369274109157190182
Interest7325333432576
Depreciation485153627792136118123142169186198
Profit before tax4583884796957921,0091,0671,3751,3881,2191,8331,8132,108
Tax %7%11%9%21%23%22%21%19%24%29%27%24%
Net Profit4243444365466117928471,1111,0538701,3331,3731,598
EPS in Rs16.1312.5215.6119.5121.7528.1229.8741.8439.6832.7650.2051.7160.18
Dividend Payout %9%23%30%32%33%34%31%24%25%31%32%31%

Compounded Sales Growth

  • 10 Years:: 19.04%
  • 5 Years:: 11.48%
  • 3 Years:: 9.69%
  • TTM:: 17.04%

Compounded Profit Growth

  • 10 Years:: 14.49%
  • 5 Years:: 9.32%
  • 3 Years:: 8.08%
  • TTM:: 19.78%

Return on Equity

  • 10 Years:: 23.45%
  • 5 Years:: 22.54%
  • 3 Years:: 63.46%
  • 1 Year:: 91.31%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -132627272727275353535353
Equity Capital132627272727275353535353
Reserves1,2491,5161,8022,1482,5273,0083,5354,3045,3565,9076,9207,264
Borrowings5333235533182742366310634
Other Liabilities -2593124575736107318865667657859611,164
Trade Payables146150121157158149224230442406483580
Advance from Customers6518101813414031382929
Other liability items107157318405434570621296293342449554
Total Liabilities1,5741,8862,3082,8033,1963,7844,4754,9656,2106,8088,0408,514
Fixed Assets -5905905907389081,2221,3091,4391,5591,9962,0872,776
Gross Block7828338851,0921,3381,7401,9522,1951,7942,3732,6333,508
Accumulated Depreciation193243296353429518644757235377546732
CWIP2024104182303144218264444120492920
Investments1724425284804115057368131,6391,8971,953979
Other Assets -7928311,0861,4031,5731,9132,2122,4502,5682,7953,5083,839
Inventories3964805436518068931,1151,1631,2561,2811,6631,744
Trade receivables2842343935345597928239661,0031,1121,2821,533
Cash Equivalents13131322353657596691105107
Loans n Advances1011066369695768141125193208315
Other asset items-1-274127105136149121118118249139
Total Assets1,5741,8862,3082,8033,1963,7844,4754,9656,2106,8088,0408,514

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -3013683263344835588221,0361,1497659641,208
Profit from operations5524105037168471,0791,1761,4451,4691,2491,9201,866
Receivables-7249-154-193-36-247-42-146-59-65-204-207
Inventory-120-84-63-108-155-87-222-48-93-26-382-81
Payables-53574524-8787156-448192
Loans Advances-15900-119-800000
Deposits130000000000
Other WC items00-0-109255239-23-8232-15
Working capital changes-21212-144-259-189-307-142-147-19-216-473-211
Direct taxes-39-55-33-123-174-213-211-261-302-269-483-446
Cash from Investing Activity --217-317-222-204-254-305-521-411-1,137-476-684-81
Fixed assets purchased-110-60-163-289-340-246-307-396-377-274-733-1,183
Fixed assets sold0000690000000
Investments purchased-167-314-668-5200-231-70-1,252-745-864-450
Investments sold51455841000-940-24254898351,484
Interest received1131263107787
Dividends received81124363026364763768437
Invest in subsidiaries00-2000000000
Inter corporate deposits00000000-3-29-102-83
Other investing items0000-153-2200088106
Cash from Financing Activity --82-48-104-131-231-248-303-6303-314-246-1,091
Proceeds from shares4265100000000
Proceeds from borrowings03837009000780
Repayment of borrowings-33-23-18-2-22-15-116000-61
Interest paid fin-4-1-1-3-1-1-1-2-2-1-4-6
Dividends paid-30-46-92-154-201-233-311-6390-319-320-1,024
Other financing items-18-7-6-10-700-66600
Net Cash Flow13-0-1-25-1-515-253436

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %41%27%28%34%33%36%32%35%28%21%28%24%
Debtor Days87921091069611597959110696105
Inventory Turnover1.470.781.161.441.271.251.381.471.471.371.441.41

Announcements & News

Recent Announcements

Credit Ratings

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Divi s Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.